Allergan announced that it has been granted a medical-device license with conditions by Health Canada to sell and market its INAMED® silicone-filled breast implants.
“This regulatory milestone is significant for Canadian women seeking breast implant surgery because they now have more options—the same options that women today have in more than 60 countries around the world,” says Kevin Skule, president and general Manager of Allergan Canada. “In addition, by approving these products, Health Canada is acknowledging the vast body of scientific evidence supporting the safety of our products.”
The implants that have been granted approval for marketing include the round, smooth, and textured implants and the Style 410 matrix, which uses a highly cohesive silicone gel to allow the implant to closely mimic the dimensions of the natural breast.
[www.newswire.ca, October 20, 2006]